Cannabinoids and dystonia: an issue yet to be defined
- 17 December 2019
- journal article
- review article
- Published by Springer Nature in Neurological Sciences
- Vol. 41 (4) , 783-787
Abstract
Dystonia is a movement disorder characterized by sustained or intermittent muscle contractions causing abnormal movements and postures. Besides motor manifestations, patients with dystonia also display non-motor signs and symptoms including psychiatric and sensory disturbances. Symptomatic treatment of motor signs in dystonia largely relies on intramuscular botulinum toxin injections and, in selected cases, on deep brain stimulation. Oral medications and physical therapy offer a few benefits only in a minority of patients. Cannabinoids have been shown to be a complementary treatment in several neurological disorders but their usefulness in dystonia have not been systematically assessed. Given recent policy changes in favor of cannabis use in clinical practice and the request for alternative treatments, it is important to understand how cannabinoids may impact people with dystonia. Reviewing the evidence so far available and our own experience, cannabinoids seem to be effective in single cases but further studies are required to improve our understanding on their role as complementary treatment in dystonia.Keywords
This publication has 30 references indexed in Scilit:
- Dystonia rating scales: Critique and recommendationsMovement Disorders, 2013
- Cannabinoid, CB1 agonists in cervical dystonia: Failure in a phase IIa randomized controlled trialBasal Ganglia, 2011
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2Pharmacological Reviews, 2010
- Does neurophysiological testing provide the information we need to improve the clinical management of primary dystonia?Clinical Neurophysiology, 2009
- Cannabis sativa and dystonia secondary to Wilson's diseaseMovement Disorders, 2004
- Δ9‐tetrahydrocannabinol improves motor control in a patient with musician's dystoniaMovement Disorders, 2004
- Quantification of focal dystonia in pianists using scale analysisMovement Disorders, 2003
- A Dramatic Response to Inhaled Cannabis in a Woman with Central Thalamic Pain and DystoniaJournal of Pain and Symptom Management, 2002
- Teaching tape for the motor section of the toronto western spasmodic torticollis scaleMovement Disorders, 1997
- Open label evaluation of cannabidiol in dystonic movement disordersInternational Journal of Neuroscience, 1986